EVAN

Evans Medical Plc Stock Price

NGSE:EVANSMED Community·₦366.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

EVANSMED Share Price Performance

₦0
0.00 (0.00%)
₦0
0.00 (0.00%)
Price ₦0

EVANSMED Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Weak fundamentals or lack of information.

3 Risks
0 Rewards

Evans Medical Plc Key Details

₦3.3b

Revenue

₦2.0b

Cost of Revenue

₦1.4b

Gross Profit

₦2.4b

Other Expenses

-₦964.8m

Earnings

Last Reported Earnings
Dec 31, 2014
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About EVANSMED

Founded
1954
Employees
n/a
CEO
n/a
Website
n/a

Evans Medical Plc manufactures, markets, and distributes health products. The company operates in the Over the Counter and Prescriptive segments. Its products include anti-malarials, ant-infectives, anti-asthamatics, anti-histaminics, analgesics, anti-ulcerants, anti-hypertensives, anti-diabetics, cold and cough preparations, erectile dysfunctions, energy supplements, herbal products, haematinics blood forming preparations, prostagladins, vitamins and minerals, topical preparations, and pharyngeals. The company was formerly known as Glaxo Nigeria Plc and changed its name to Evans Medical Plc in 1994. Evans Medical Plc was founded in 1954 and is based in Lagos, Nigeria.

Recent EVANSMED News & Updates

Recent updates

No updates